CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.1000
-0.024536 (-19.70%)
At close: Apr 17, 2026
CS Diagnostics Market Cap
CS Diagnostics has a market cap or net worth of $25 million as of April 17, 2026. Its market cap has increased by 3.72% in one year.
Market Cap
25.00M
Enterprise Value
24.99M
Revenue
204.00K
Ranking
n/a
PE Ratio
351.02
Stock Price
$0.10
Market Cap Chart
Since March 31, 2016, CS Diagnostics's market cap has increased from 738.94K to 25.00M, an increase of 3,283.14%. That is a compound annual growth rate of 41.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 25.00M | -67.31% |
| Dec 31, 2025 | 76.47M | -49.21% |
| Dec 31, 2024 | 150.56M | 38,005.96% |
| Dec 29, 2023 | 395.10K | -47.85% |
| Dec 23, 2022 | 757.61K | 5,499.87% |
| Dec 31, 2021 | 13.53K | -98.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zomedica | 101.65M |
| RetinalGenix Technologies | 59.54M |
| Positron | 59.46M |
| Vivos | 33.80M |
| Family Office of America | 30.10M |
| PetVivo Holdings | 28.24M |
| Guided Therapeutics | 18.34M |
| Allurion Technologies | 11.55M |